1 |
Murray JF, Matthay MA, Luce JM, Flick MR. An expanded definition of the adult respiratory distress syndrome. Am Rev Respir Dis 1988;138:720-3
DOI
ScienceOn
|
2 |
Park II, Kim IK, Koo HC, Han JP, Kim YM, Lee MG, et al. Clinical characteristics and prognosis of acinetobacter nosocomial pneumonia between MDR and non-MDR. Tuberc Respir Dis 2006;61:13-9
DOI
ScienceOn
|
3 |
Saballs M, Pujol M, Tubau F, Pena C, Montero A, Dominguez MA, et al. Rifampicin/imipenem combination in the treatment of carbapenem-resistant Acinetobacter baumannii infections. J Antimicrob Chemother 2006;58:697-700
DOI
ScienceOn
|
4 |
Wood GC, Swanson JM. Aerosolised antibacterials for the prevention and treatment of hospital-acquired pneumonia. Drugs 2007;67:903-14
DOI
ScienceOn
|
5 |
Lee MA, Moon HW. In vitro activity of antimicrobial combination against multidrug-resistant strains of acinetobacter baumannii. Korean J Lab Med 2005;25:312-6
|
6 |
Hanberger H, Garcia-Rodriguez JA, Gobernado M, Goossens H, Nilsson LE, Struelens MJ. Antibiotic susceptibility among aerobic gram-negative bacilli in intensive care units in 5 European countries. French and Portuguese ICU Study Groups. JAMA 1999;281:67-71
DOI
ScienceOn
|
7 |
Luna CM, Aruj PK. Nosocomial Acinetobacter pneumonia. Respirology 2007;12:787-91
DOI
ScienceOn
|
8 |
Diomedi A. Acinetobacter baumannii pandrug-resistant: update in epidemiological and antimicrobial managing issues. Rev Chilena Infectol 2005;22:298-320
|
9 |
Cisneros-Herreros JM, Garnacho-Montero J, Pachon-Ibanez ME. Nosocomial pneumonia due to Acinetobacter baumannii. Enferm Infecc Microbiol Clin 2005; 23 Suppl 3:46-51
DOI
|
10 |
Wilks M, Wilson A, Warwick S, Price E, Kennedy D, Ely A, et al. Control of an outbreak of multidrug- resistant Acinetobacter baumannii-calcoaceticus colonization and infection in an intensive care unit (ICU) without closing the ICU or placing patients in isolation. Infect Control Hosp Epidemiol 2006;27:654-8
DOI
ScienceOn
|
11 |
Falagas ME, Kasiakou SK. Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections. Clin Infect Dis 2005;40:1333-41
DOI
ScienceOn
|
12 |
Alothman GA, Ho B, Alsaadi MM, Ho SL, O'Drowsky L, Louca E, et al. Bronchial constriction and inhaled colistin in cystic fibrosis. Chest 2005;127:522-9
DOI
ScienceOn
|
13 |
Michalopoulos A, Kasiakou SK, Mastora Z, Rellos K, Kapaskelis AM, Falagas ME. Aerosolized colistin for the treatment of nosocomial pneumonia due to multidrugresistant Gram-negative bacteria in patients without cystic fibrosis. Crit Care 2005;9:R53-9
DOI
|
14 |
Lee SW, Jo HS, Kim WJ. Clinical characteristics of intensive care unit patients with carbapenem resistant acinetobacter baumannii isolated from sputum. Tuberc Respir Dis 2006;60:228-34
DOI
ScienceOn
|
15 |
Kwa AL, Loh C, Low JG, Kurup A, Tam VH. Nebulized colistin in the treatment of pneumonia due to multidrugresistant Acinetobacter baumannii and Pseudomonas aeruginosa. Clin Infect Dis 2005;41:754-7
DOI
ScienceOn
|
16 |
Beringer P. The clinical use of colistin in patients with cystic fibrosis. Curr Opin Pulm Med 2001;7:434-40
DOI
ScienceOn
|
17 |
Paul M, Weinberger M, Siegman-Igra Y, Lazarovitch T, Ostfeld I, Boldur I, et al. Acinetobacter baumannii: emergence and spread in Israeli hospitals 1997-2002. J Hosp Infect 2005;60:256-60
DOI
ScienceOn
|
18 |
Falagas ME, Kasiakou SK, Tsiodras S, Michalopoulos A. The use of intravenous and aerosolized polymyxins for the treatment of infections in critically ill patients: a review of the recent literature. Clin Med Res 2006;4: 138-46
DOI
ScienceOn
|
19 |
Pereira GH, Muller PR, Levin AS. Salvage treatment of pneumonia and initial treatment of tracheobronchitis caused by multidrug-resistant Gram-negative bacilli with inhaled polymyxin B. Diagn Microbiol Infect Dis 2007;58:235-40
DOI
ScienceOn
|
20 |
Reina R, Estenssoro E, Saenz G, Canales HS, Gonzalvo R, Vidal G, et al. Safety and efficacy of colistin in Acinetobacter and Pseudomonas infections: a prospective cohort study. Intensive Care Med 2005;31:1058-65
DOI
|
21 |
Ling ML, Ang A, Wee M, Wang GC. A nosocomial outbreak of multiresistant Acinetobacter baumannii originating from an intensive care unit. Infect Control Hosp Epidemiol 2001;22:48-9
DOI
ScienceOn
|
22 |
Murray CK, Hospenthal DR. Treatment of multidrug resistant Acinetobacter. Curr Opin Infect Dis 2005;18:502-6
DOI
ScienceOn
|
23 |
Bergogne-Berezin E. The increasing significance of outbreaks of Acinetobacter spp.: the need for control and new agents. J Hosp Infect 1995;30 Suppl:441-52
DOI
|
24 |
Trottier V, Namias N, Pust DG, Nuwayhid Z, Manning R, Marttos AC, et al. Outcomes of Acinetobacter baumannii infection in critically ill surgical patients. Surg Infect (Larchmt) 2007;8:437-43
DOI
ScienceOn
|